Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Options
Restricted Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Restricted Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Sep. 30, 2020       25,268,848        
Beginning Balance at Sep. 30, 2020 $ 11,080     $ 3 $ 48,215   $ 0 $ (37,138)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)       765,046        
Issuance of common stock upon exercise of stock options 144       144      
Issuance of common stock upon settlement of restricted stock units (in shares)       790,497        
Stock-based compensation - restricted stock   $ 1,013 $ 8,608     $ 8,608    
Shares withheld related to net share settlement (in shares)       (6,011)        
Shares withheld related to net share settlement (52)       (52)      
EIC shares recapitalization, net of issuance costs and the fair value of warrant liabilities (in shares)       30,778,021        
EIC shares capitalized, net of issuance costs and the fair value of warrant liabilities 191,151     $ 3 191,148      
Shares issued in PIPE, net of issuance costs (in shares)       12,500,000        
Shares issued in PIPE, net of issuance costs 119,634     $ 1 119,633      
Other comprehensive income (loss) (297)           (297)  
Net income (loss) (40,052)             (40,052)
Ending Balance (in shares) at Sep. 30, 2021       70,096,401        
Ending Balance at Sep. 30, 2021 291,229     $ 7 368,709   (297) (77,190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)       893,509        
Issuance of common stock upon exercise of stock options 161       161      
Issuance of common stock upon settlement of restricted stock units (in shares)       51,848        
Stock-based compensation - restricted stock     $ 2,931     $ 2,931    
Shares withheld related to net share settlement (in shares)       (374,377)        
Shares withheld related to net share settlement (3,121)       (3,121)      
Other comprehensive income (loss) (601)           (601)  
Net income (loss) 772             772
Ending Balance (in shares) at Dec. 31, 2021       70,667,381        
Ending Balance at Dec. 31, 2021 291,371     $ 7 368,680   (898) (76,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)   480,812            
Other comprehensive income (loss) 3,185              
Net income (loss) (27,260)              
Ending Balance (in shares) at Dec. 31, 2022       71,660,617        
Ending Balance at Dec. 31, 2022 $ 274,489     $ 7 $ 375,873   $ 2,287 $ (103,678)